Biopharmaceutical Product Attributes and Biological Consequences Community

 View Only

PLEASE JOIN -- EXCIPIENTS/BPABC OSD APRIL 20 NOON TO 1PM EST: DIFFERENTIAL SURFACE ADSORPTION PHENOMENA FOR CONVENTIONAL AND NOVEL SURFACTANTS CORRELATES WITH CHANGES IN INTERFACIAL MAB STABILIZATION

  • 1.  PLEASE JOIN -- EXCIPIENTS/BPABC OSD APRIL 20 NOON TO 1PM EST: DIFFERENTIAL SURFACE ADSORPTION PHENOMENA FOR CONVENTIONAL AND NOVEL SURFACTANTS CORRELATES WITH CHANGES IN INTERFACIAL MAB STABILIZATION

    Community Leadership
    Posted 04-17-2023 11:50

    Please join the following OSD this week.  We will be cancelling our monthly meeting that is scheduled for the same time.  Hope to see some of you there!


    Join us Thursday, April 20 from noon to 1 pm EST for an Open Scientific Discussion:

    Differential Surface Adsorption Phenomena for Conventional and Novel Surfactants Correlates with Changes in Interfacial mAb Stabilization
    Ankit Kanthe, Formulation and Analytical Scientist, Bristol Myers Squibb

    The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.2c00152.

    Langmuir adsorption isotherm fit to determine cmc and maximum surface coverage for PS80 and FM1000; X-ray reflectivity data analysis; surface concentration calculations for single component (mAb or PS80 orFM1000) and mixed component (mAb + PS80 or mAb + FM1000); homology modeling along with the estimate for mAb size; XRR profile with the corresponding EDP for pure PS80, pure FM1000, mAb + PS80, and mAb + FM1000; and overlapping XRR measurements to compare the mixed component system alongside the pure mAb and pure surfactant XRR data (PDF)

     

    Cohosted by the Excipients and the Biopharmaceutical Product Attributes and Biological Consequences (BPABC) Communities



    ------------------------------
    Srivalli Telikepalli Ph.D.
    Research Chemist
    National Institute of Standards and Technology
    Gaithersburg MD
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------